Waldenström Macroglobulinemia: A Plasma Cell Neoplasm with IgM Monoclonal Gammopathy
Waldenström macroglobulinemia (WM) is a rare, indolent B-cell lymphoproliferative disorder classified as a plasma cell neoplasm (specifically, a lymphoplasmacytic lymphoma with an IgM monoclonal gammopathy).
Key Features
- Clonal expansion of lymphoplasmacytic cells in bone marrow, lymph nodes, and spleen.
- Overproduction of monoclonal immunoglobulin M (IgM), causing hyperviscosity syndrome in advanced cases.
- Median age at diagnosis: ~70 years.
- Genetic hallmark: MYD88 L265P mutation (>90% of cases); CXCR4 mutations in ~30–40%.
Clinical Presentation
- Fatigue, weight loss, night sweats (B symptoms).
- Hyperviscosity: visual changes, headaches, bleeding, neurologic symptoms.
- Anemia, thrombocytopenia (marrow infiltration).
- Peripheral neuropathy (anti-myelin-associated glycoprotein antibodies).
- Hepatosplenomegaly, lymphadenopathy.
Management
Asymptomatic patients may be observed. Treatment (e.g., BTK inhibitors like ibrutinib, rituximab-based regimens, plasmapheresis for acute hyperviscosity) is initiated for symptomatic disease. Prognosis is generally favorable with modern therapies.
Blood Disorders - Related Articles
- Average Blood Volume in Adult Women: What the Numbers Mean
- Renal Reabsorption: Key Substances, Sites, Mechanisms & Regulation
- Blood Type Inheritance: Can Type A and Type B Parents Have a Type O Child?
- Blood Clot Treatments: Medications, Surgery & More
- Understanding the Genetic Factors of Coronary Artery Disease
- ITP Treatments: Latest Advances and Options
- Mild Biparietal Atrophy: Causes, Symptoms, and Clinical Significance
